Guideline for the diagnosis and management of hypertension in adults — 2016

Anthony Rodgers, Clara K Chow, Rodney T Jackson, Anushka Patel and Tim Usherwood
Med J Aust 2017; 206 (3): . || doi: 10.5694/mja16.01057
Published online: 20 February 2017

To the Editor:

  • 1 The George Institute for Global Health, Sydney, NSW
  • 2 University of Sydney, Sydney, NSW
  • 3 Westmead Hospital, Sydney, NSW
  • 4 University of Auckland, Auckland, NZ


We thank John Chalmers, Bruce Neal and Emily Atkins of The George Institute for Global Health for their assistance in preparing this letter.

Competing interests:

George Health Enterprises, the social enterprise arm of The George Institute for Global Health, has received investment to develop aspirin–statin–BP combinations.

  • 1. Gabb GM, Mangoni AA, Anderson CS, et al. Guideline for the diagnosis and management of hypertension in adults – 2016. Med J Aust 2016; 205: 85-89. <MJA full text>
  • 2. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. Melbourne: National Stroke Foundation, 2012.
  • 3. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387: 957-967.
  • 4. Xie X, Atkins E, Lv J, Rodgers A. Intensive blood pressure lowering–Authors' reply. Lancet. 2016; 387: 2291.
  • 5. Mancia G, Sega R, Bravi C, De Vito G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13: 1377-1390.
  • 6. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011; 378: 1219-1230.
  • 7. National Heart Foundation of Australia. Guideline for the diagnosis and management of hypertension in adults 2016. Melbourne: NHF, 2016.
  • 8. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
  • 9. Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular disease events, and blood pressure-and lipid-lowering therapy in Australia. Med J Aust 2016; 204: 320. <MJA full text>


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.